 Jonathan Samet
Concepts (1003)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Air Pollution | 74 | 2026 | 314 | 11.530 |
Why?
| | Smoking | 108 | 2018 | 1472 | 9.020 |
Why?
| | Air Pollutants | 73 | 2025 | 405 | 7.760 |
Why?
| | Environmental Exposure | 75 | 2026 | 578 | 7.370 |
Why?
| | Tobacco Smoke Pollution | 52 | 2016 | 227 | 7.280 |
Why?
| | Public Health | 54 | 2025 | 572 | 6.910 |
Why?
| | Neoplasms, Radiation-Induced | 33 | 2025 | 100 | 5.870 |
Why?
| | Smoking Prevention | 25 | 2021 | 166 | 4.990 |
Why?
| | Air Pollution, Indoor | 30 | 2024 | 171 | 4.440 |
Why?
| | Lung Neoplasms | 69 | 2026 | 2664 | 4.330 |
Why?
| | Epidemiology | 20 | 2020 | 32 | 4.110 |
Why?
| | Particulate Matter | 37 | 2025 | 326 | 4.090 |
Why?
| | Global Health | 22 | 2020 | 403 | 3.860 |
Why?
| | Tobacco Products | 17 | 2024 | 84 | 3.560 |
Why?
| | Smoking Cessation | 27 | 2021 | 440 | 3.540 |
Why?
| | Tobacco Industry | 19 | 2018 | 25 | 3.540 |
Why?
| | Respiratory Tract Diseases | 30 | 2026 | 175 | 3.450 |
Why?
| | Occupational Exposure | 27 | 2025 | 355 | 3.360 |
Why?
| | Radon | 28 | 2024 | 43 | 3.130 |
Why?
| | Mortality | 31 | 2024 | 378 | 2.950 |
Why?
| | Neoplasms | 35 | 2025 | 2906 | 2.910 |
Why?
| | Environmental Health | 14 | 2021 | 40 | 2.830 |
Why?
| | Occupational Diseases | 19 | 2024 | 165 | 2.690 |
Why?
| | Environmental Monitoring | 28 | 2024 | 346 | 2.510 |
Why?
| | Humans | 448 | 2026 | 145474 | 2.430 |
Why?
| | Uranium | 18 | 2025 | 27 | 2.420 |
Why?
| | Carcinogens | 9 | 2022 | 123 | 2.190 |
Why?
| | Electronic Nicotine Delivery Systems | 15 | 2024 | 110 | 2.150 |
Why?
| | United States | 125 | 2026 | 16098 | 2.020 |
Why?
| | Health Policy | 19 | 2020 | 400 | 1.960 |
Why?
| | Cardiovascular Diseases | 29 | 2017 | 2187 | 1.930 |
Why?
| | Ozone | 11 | 2024 | 115 | 1.880 |
Why?
| | Nuclear Weapons | 2 | 2025 | 7 | 1.780 |
Why?
| | Mining | 18 | 2025 | 36 | 1.750 |
Why?
| | Dronabinol | 3 | 2025 | 249 | 1.610 |
Why?
| | Epidemiologic Methods | 20 | 2012 | 91 | 1.570 |
Why?
| | Epidemiologic Studies | 9 | 2024 | 68 | 1.450 |
Why?
| | Risk Assessment | 42 | 2020 | 3747 | 1.450 |
Why?
| | Research | 13 | 2014 | 430 | 1.420 |
Why?
| | Politics | 7 | 2024 | 92 | 1.400 |
Why?
| | United States Environmental Protection Agency | 10 | 2020 | 28 | 1.390 |
Why?
| | Research Design | 15 | 2025 | 1137 | 1.350 |
Why?
| | History, 20th Century | 15 | 2025 | 328 | 1.340 |
Why?
| | Tobacco Use Disorder | 8 | 2015 | 217 | 1.300 |
Why?
| | Climate Change | 8 | 2026 | 177 | 1.290 |
Why?
| | Environmental Policy | 3 | 2020 | 6 | 1.280 |
Why?
| | Respiration Disorders | 7 | 2022 | 78 | 1.180 |
Why?
| | Biomedical Research | 11 | 2020 | 717 | 1.180 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 10 | 2025 | 919 | 1.160 |
Why?
| | Forecasting | 13 | 2020 | 390 | 1.150 |
Why?
| | Risk Factors | 80 | 2025 | 10885 | 1.110 |
Why?
| | Developing Countries | 7 | 2014 | 316 | 1.100 |
Why?
| | Ventilation | 4 | 2024 | 44 | 1.070 |
Why?
| | Urban Health | 8 | 2014 | 96 | 1.040 |
Why?
| | Cost of Illness | 5 | 2018 | 324 | 1.040 |
Why?
| | Cannabis | 2 | 2025 | 509 | 1.040 |
Why?
| | Lung Diseases | 12 | 2018 | 780 | 1.010 |
Why?
| | Nicotine | 18 | 2016 | 331 | 1.000 |
Why?
| | Menthol | 5 | 2021 | 11 | 1.000 |
Why?
| | Inhalation Exposure | 7 | 2017 | 103 | 0.990 |
Why?
| | Causality | 8 | 2016 | 126 | 0.990 |
Why?
| | Nuclear Warfare | 4 | 2024 | 10 | 0.980 |
Why?
| | Models, Statistical | 17 | 2016 | 671 | 0.980 |
Why?
| | Cohort Studies | 38 | 2025 | 6013 | 0.940 |
Why?
| | Maternal Exposure | 5 | 2016 | 189 | 0.930 |
Why?
| | Guidelines as Topic | 4 | 2020 | 266 | 0.920 |
Why?
| | International Agencies | 5 | 2022 | 30 | 0.910 |
Why?
| | Cotinine | 10 | 2014 | 77 | 0.910 |
Why?
| | Health Status Disparities | 3 | 2019 | 321 | 0.890 |
Why?
| | History, 21st Century | 8 | 2025 | 222 | 0.870 |
Why?
| | Soft Tissue Neoplasms | 4 | 2026 | 131 | 0.840 |
Why?
| | Particle Size | 19 | 2014 | 381 | 0.840 |
Why?
| | Male | 155 | 2025 | 72842 | 0.840 |
Why?
| | Cell Phone | 3 | 2014 | 82 | 0.840 |
Why?
| | Environmental Pollutants | 3 | 2019 | 139 | 0.840 |
Why?
| | Female | 155 | 2025 | 78844 | 0.840 |
Why?
| | Tuberculosis | 2 | 2019 | 283 | 0.840 |
Why?
| | Magnetic Resonance Imaging | 10 | 2026 | 3904 | 0.830 |
Why?
| | Asbestos | 5 | 2019 | 36 | 0.830 |
Why?
| | Government Regulation | 5 | 2017 | 39 | 0.830 |
Why?
| | Vaping | 6 | 2024 | 74 | 0.800 |
Why?
| | Sleep Apnea Syndromes | 6 | 2016 | 98 | 0.800 |
Why?
| | Population Health | 1 | 2024 | 44 | 0.800 |
Why?
| | Cause of Death | 12 | 2016 | 470 | 0.790 |
Why?
| | Adult | 105 | 2025 | 40777 | 0.790 |
Why?
| | Conservation of Natural Resources | 3 | 2020 | 119 | 0.790 |
Why?
| | Environmental Pollution | 2 | 2020 | 20 | 0.760 |
Why?
| | Health Equity | 3 | 2021 | 133 | 0.760 |
Why?
| | Public Policy | 11 | 2015 | 80 | 0.760 |
Why?
| | Aged | 89 | 2025 | 26153 | 0.750 |
Why?
| | Vehicle Emissions | 7 | 2023 | 57 | 0.740 |
Why?
| | Advisory Committees | 4 | 2020 | 229 | 0.740 |
Why?
| | Urban Population | 12 | 2009 | 493 | 0.740 |
Why?
| | Child Health | 1 | 2024 | 153 | 0.740 |
Why?
| | Flavoring Agents | 3 | 2016 | 10 | 0.720 |
Why?
| | Asthma | 14 | 2014 | 1797 | 0.720 |
Why?
| | Incidence | 21 | 2024 | 2923 | 0.690 |
Why?
| | United States Food and Drug Administration | 5 | 2017 | 208 | 0.690 |
Why?
| | Brachial Plexus Neuropathies | 1 | 2021 | 18 | 0.670 |
Why?
| | Middle Aged | 98 | 2025 | 36215 | 0.670 |
Why?
| | Leadership | 6 | 2024 | 401 | 0.670 |
Why?
| | Brachial Plexus | 1 | 2021 | 34 | 0.670 |
Why?
| | Abnormalities, Radiation-Induced | 1 | 2020 | 1 | 0.660 |
Why?
| | Public Health Practice | 3 | 2019 | 63 | 0.660 |
Why?
| | Heart Diseases | 5 | 2013 | 341 | 0.660 |
Why?
| | Tobacco Smoking | 1 | 2020 | 27 | 0.650 |
Why?
| | Anniversaries and Special Events | 1 | 2020 | 16 | 0.650 |
Why?
| | Disease | 2 | 2019 | 96 | 0.650 |
Why?
| | New Mexico | 37 | 2002 | 99 | 0.650 |
Why?
| | Science | 2 | 2022 | 55 | 0.640 |
Why?
| | Social Control, Formal | 1 | 2020 | 10 | 0.620 |
Why?
| | Research Support as Topic | 6 | 2014 | 80 | 0.610 |
Why?
| | Smokers | 1 | 2020 | 138 | 0.610 |
Why?
| | Smoke | 4 | 2020 | 148 | 0.600 |
Why?
| | Health Care Costs | 3 | 2014 | 425 | 0.600 |
Why?
| | Risk | 22 | 2016 | 919 | 0.590 |
Why?
| | Viruses | 1 | 2021 | 165 | 0.590 |
Why?
| | Radiation Exposure | 3 | 2025 | 63 | 0.590 |
Why?
| | Epidemiologists | 1 | 2019 | 5 | 0.590 |
Why?
| | Filtration | 3 | 2017 | 68 | 0.580 |
Why?
| | Carcinogens, Environmental | 4 | 2015 | 14 | 0.580 |
Why?
| | Indians, North American | 14 | 1995 | 597 | 0.580 |
Why?
| | Mexico | 15 | 2019 | 233 | 0.560 |
Why?
| | Morbidity | 7 | 2017 | 322 | 0.560 |
Why?
| | Minority Groups | 4 | 2017 | 284 | 0.550 |
Why?
| | International Cooperation | 10 | 2012 | 197 | 0.550 |
Why?
| | Obesity, Abdominal | 1 | 2018 | 47 | 0.540 |
Why?
| | Professional Competence | 4 | 2019 | 91 | 0.540 |
Why?
| | Publications | 2 | 2015 | 47 | 0.540 |
Why?
| | Chernobyl Nuclear Accident | 1 | 2017 | 5 | 0.540 |
Why?
| | Proportional Hazards Models | 13 | 2025 | 1327 | 0.530 |
Why?
| | Smoke-Free Policy | 2 | 2018 | 13 | 0.530 |
Why?
| | Environmental Illness | 1 | 2017 | 3 | 0.530 |
Why?
| | Respiratory Tract Infections | 6 | 2024 | 396 | 0.530 |
Why?
| | Climate | 5 | 2013 | 77 | 0.520 |
Why?
| | Age Factors | 20 | 2020 | 3342 | 0.510 |
Why?
| | Japan | 6 | 2025 | 149 | 0.510 |
Why?
| | Cyclonic Storms | 1 | 2018 | 40 | 0.510 |
Why?
| | Saliva | 6 | 2014 | 246 | 0.510 |
Why?
| | Radiology Information Systems | 3 | 2026 | 35 | 0.510 |
Why?
| | Biomarkers, Tumor | 4 | 2025 | 1321 | 0.500 |
Why?
| | Air Pollutants, Radioactive | 5 | 2006 | 8 | 0.500 |
Why?
| | Chronic Disease | 4 | 2015 | 1808 | 0.490 |
Why?
| | Evidence-Based Practice | 5 | 2018 | 231 | 0.480 |
Why?
| | Harm Reduction | 4 | 2021 | 49 | 0.480 |
Why?
| | Organizational Policy | 2 | 2014 | 78 | 0.480 |
Why?
| | Pandemics | 3 | 2024 | 1707 | 0.480 |
Why?
| | Cities | 6 | 2024 | 138 | 0.480 |
Why?
| | World Health Organization | 7 | 2016 | 104 | 0.480 |
Why?
| | Perinatal Death | 1 | 2016 | 26 | 0.480 |
Why?
| | Radiation Injuries | 1 | 2017 | 149 | 0.480 |
Why?
| | Biological Transport, Active | 1 | 2016 | 69 | 0.480 |
Why?
| | Nitrogen Dioxide | 7 | 2023 | 45 | 0.470 |
Why?
| | Breast Neoplasms | 12 | 2009 | 2382 | 0.470 |
Why?
| | Prospective Studies | 22 | 2024 | 8057 | 0.470 |
Why?
| | Prevalence | 18 | 2020 | 2865 | 0.460 |
Why?
| | Histiocytosis, Langerhans-Cell | 1 | 2016 | 36 | 0.460 |
Why?
| | Stillbirth | 1 | 2016 | 81 | 0.460 |
Why?
| | Hazardous Substances | 4 | 2015 | 16 | 0.460 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2019 | 297 | 0.450 |
Why?
| | Hospitalization | 9 | 2009 | 2460 | 0.450 |
Why?
| | Population Surveillance | 10 | 2018 | 484 | 0.450 |
Why?
| | Cigarette Smoking | 4 | 2020 | 102 | 0.450 |
Why?
| | gamma-Glutamyltransferase | 1 | 2015 | 42 | 0.450 |
Why?
| | Obesity | 7 | 2018 | 3116 | 0.450 |
Why?
| | Bone Diseases | 1 | 2016 | 61 | 0.450 |
Why?
| | Tobacco Use | 1 | 2016 | 62 | 0.440 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 389 | 0.440 |
Why?
| | Coronavirus Infections | 1 | 2020 | 383 | 0.440 |
Why?
| | Organizations | 1 | 2015 | 28 | 0.440 |
Why?
| | Nicotinic Agonists | 3 | 2013 | 135 | 0.440 |
Why?
| | Time Factors | 31 | 2019 | 7123 | 0.440 |
Why?
| | Dose-Response Relationship, Radiation | 5 | 2011 | 140 | 0.430 |
Why?
| | Body Mass Index | 7 | 2016 | 2445 | 0.430 |
Why?
| | Republic of Korea | 6 | 2019 | 43 | 0.430 |
Why?
| | Aged, 80 and over | 25 | 2025 | 8333 | 0.430 |
Why?
| | Epidemics | 1 | 2016 | 96 | 0.420 |
Why?
| | Health Services Accessibility | 4 | 2017 | 1101 | 0.420 |
Why?
| | Social Discrimination | 1 | 2014 | 9 | 0.420 |
Why?
| | Health Facility Administration | 1 | 2014 | 7 | 0.420 |
Why?
| | Case-Control Studies | 21 | 2016 | 3623 | 0.410 |
Why?
| | Linear Models | 9 | 2018 | 845 | 0.410 |
Why?
| | Alkaloids | 1 | 2014 | 28 | 0.410 |
Why?
| | Data Collection | 9 | 2019 | 640 | 0.400 |
Why?
| | Odds Ratio | 15 | 2019 | 1082 | 0.400 |
Why?
| | Carbon Monoxide | 5 | 2022 | 82 | 0.400 |
Why?
| | Behavior | 1 | 2014 | 89 | 0.400 |
Why?
| | Health Promotion | 6 | 2013 | 775 | 0.400 |
Why?
| | Tuberculosis, Pulmonary | 2 | 2016 | 127 | 0.400 |
Why?
| | Aerosols | 5 | 2021 | 145 | 0.400 |
Why?
| | Lung | 12 | 2016 | 4106 | 0.390 |
Why?
| | Adolescent Behavior | 4 | 2016 | 494 | 0.390 |
Why?
| | Bronchi | 7 | 2000 | 263 | 0.390 |
Why?
| | Bone Neoplasms | 2 | 2026 | 259 | 0.390 |
Why?
| | Vanadium | 7 | 2009 | 9 | 0.380 |
Why?
| | Europe | 8 | 2024 | 418 | 0.380 |
Why?
| | Abortion, Spontaneous | 1 | 2014 | 118 | 0.380 |
Why?
| | Hot Temperature | 3 | 2014 | 396 | 0.380 |
Why?
| | Personnel Selection | 1 | 2014 | 91 | 0.370 |
Why?
| | Sex Distribution | 8 | 2019 | 387 | 0.370 |
Why?
| | Workplace | 5 | 2011 | 272 | 0.370 |
Why?
| | Child | 35 | 2025 | 22707 | 0.370 |
Why?
| | Australia | 6 | 2024 | 288 | 0.370 |
Why?
| | Regression Analysis | 10 | 2018 | 1001 | 0.370 |
Why?
| | Preventive Medicine | 1 | 2012 | 39 | 0.370 |
Why?
| | Canada | 4 | 2024 | 431 | 0.360 |
Why?
| | Medicare | 7 | 2012 | 903 | 0.360 |
Why?
| | Surveys and Questionnaires | 28 | 2024 | 6066 | 0.360 |
Why?
| | Life Expectancy | 1 | 2013 | 73 | 0.360 |
Why?
| | Lead | 6 | 2015 | 71 | 0.360 |
Why?
| | Korea | 6 | 2015 | 18 | 0.360 |
Why?
| | Societies, Medical | 10 | 2026 | 899 | 0.360 |
Why?
| | Adolescent | 40 | 2025 | 22529 | 0.350 |
Why?
| | Child Welfare | 3 | 2004 | 233 | 0.350 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2019 | 686 | 0.350 |
Why?
| | Research Report | 1 | 2012 | 86 | 0.350 |
Why?
| | Exercise | 4 | 2021 | 2198 | 0.350 |
Why?
| | Diabetes Mellitus | 2 | 2019 | 1097 | 0.350 |
Why?
| | Health Surveys | 9 | 2017 | 518 | 0.350 |
Why?
| | Respiratory Sounds | 4 | 2024 | 103 | 0.350 |
Why?
| | Meningioma | 2 | 2010 | 88 | 0.350 |
Why?
| | Genetic Predisposition to Disease | 5 | 2014 | 2378 | 0.350 |
Why?
| | Data Interpretation, Statistical | 5 | 2008 | 368 | 0.340 |
Why?
| | Adenocarcinoma | 4 | 2017 | 925 | 0.340 |
Why?
| | Miners | 2 | 2022 | 3 | 0.340 |
Why?
| | Coal | 3 | 2022 | 18 | 0.340 |
Why?
| | Drug and Narcotic Control | 1 | 2011 | 24 | 0.330 |
Why?
| | Leukocyte Count | 2 | 2005 | 316 | 0.330 |
Why?
| | Heat Stress Disorders | 2 | 2002 | 84 | 0.330 |
Why?
| | Copying Processes | 1 | 2010 | 1 | 0.330 |
Why?
| | Idiopathic Pulmonary Fibrosis | 2 | 2015 | 692 | 0.330 |
Why?
| | China | 8 | 2012 | 270 | 0.330 |
Why?
| | Americas | 3 | 2019 | 27 | 0.320 |
Why?
| | Veterans Disability Claims | 1 | 2010 | 4 | 0.320 |
Why?
| | Dose-Response Relationship, Drug | 7 | 2016 | 2028 | 0.320 |
Why?
| | Women's Health | 2 | 2010 | 314 | 0.320 |
Why?
| | Seasons | 10 | 2021 | 538 | 0.320 |
Why?
| | Wildfires | 2 | 2021 | 42 | 0.320 |
Why?
| | Mass Screening | 1 | 2019 | 1360 | 0.310 |
Why?
| | Congresses as Topic | 5 | 2018 | 223 | 0.310 |
Why?
| | Brazil | 4 | 2019 | 179 | 0.310 |
Why?
| | Air Microbiology | 3 | 2024 | 37 | 0.310 |
Why?
| | Education, Public Health Professional | 2 | 2008 | 10 | 0.310 |
Why?
| | Career Choice | 2 | 2010 | 234 | 0.310 |
Why?
| | September 11 Terrorist Attacks | 2 | 2007 | 31 | 0.310 |
Why?
| | Young Adult | 21 | 2025 | 14218 | 0.300 |
Why?
| | Product Packaging | 3 | 2020 | 6 | 0.300 |
Why?
| | Health | 4 | 2018 | 82 | 0.300 |
Why?
| | Rural Health | 2 | 2007 | 87 | 0.300 |
Why?
| | Child, Preschool | 19 | 2024 | 11853 | 0.300 |
Why?
| | Carcinogenesis | 2 | 2022 | 228 | 0.300 |
Why?
| | Sex Factors | 14 | 2015 | 2105 | 0.290 |
Why?
| | Hair | 6 | 2014 | 84 | 0.290 |
Why?
| | Cystic Fibrosis | 3 | 2014 | 1161 | 0.290 |
Why?
| | Tobacco, Smokeless | 4 | 2016 | 13 | 0.290 |
Why?
| | Blood Glucose | 4 | 2022 | 2341 | 0.280 |
Why?
| | Housing | 7 | 2011 | 142 | 0.280 |
Why?
| | Deception | 1 | 2008 | 18 | 0.280 |
Why?
| | Expert Testimony | 2 | 2006 | 42 | 0.280 |
Why?
| | Glioma | 2 | 2010 | 429 | 0.270 |
Why?
| | Alcohol Drinking | 3 | 2005 | 837 | 0.270 |
Why?
| | Commerce | 4 | 2021 | 80 | 0.270 |
Why?
| | Effect Modifier, Epidemiologic | 1 | 2007 | 8 | 0.260 |
Why?
| | Spirometry | 4 | 2016 | 233 | 0.260 |
Why?
| | Air Pollutants, Occupational | 4 | 2008 | 41 | 0.260 |
Why?
| | Information Dissemination | 2 | 2010 | 224 | 0.260 |
Why?
| | Biomarkers | 10 | 2017 | 4295 | 0.260 |
Why?
| | Evidence-Based Medicine | 6 | 2014 | 740 | 0.260 |
Why?
| | Diagnosis, Differential | 5 | 2026 | 1508 | 0.260 |
Why?
| | Environment, Controlled | 2 | 2006 | 22 | 0.260 |
Why?
| | Construction Materials | 1 | 2007 | 18 | 0.260 |
Why?
| | Musculoskeletal Diseases | 2 | 2025 | 90 | 0.250 |
Why?
| | Registries | 8 | 2022 | 2406 | 0.250 |
Why?
| | Professional Role | 3 | 2019 | 169 | 0.250 |
Why?
| | Foundations | 3 | 2018 | 27 | 0.250 |
Why?
| | Education | 2 | 2018 | 104 | 0.250 |
Why?
| | Bias | 6 | 2018 | 197 | 0.250 |
Why?
| | Ontario | 3 | 2019 | 90 | 0.240 |
Why?
| | Marketing | 4 | 2021 | 23 | 0.240 |
Why?
| | Growth Disorders | 1 | 2007 | 89 | 0.240 |
Why?
| | Muscle Neoplasms | 1 | 2026 | 9 | 0.240 |
Why?
| | Social Environment | 2 | 2019 | 252 | 0.240 |
Why?
| | Tomography, X-Ray Computed | 2 | 2007 | 2769 | 0.240 |
Why?
| | Los Angeles | 4 | 2024 | 73 | 0.230 |
Why?
| | Academies and Institutes | 4 | 2022 | 61 | 0.230 |
Why?
| | Sarcoma, Small Cell | 1 | 2025 | 2 | 0.230 |
Why?
| | Thymus Neoplasms | 1 | 2026 | 30 | 0.230 |
Why?
| | RNA-Binding Protein FUS | 1 | 2025 | 13 | 0.230 |
Why?
| | Publishing | 2 | 2014 | 114 | 0.230 |
Why?
| | Radon Daughters | 5 | 2022 | 5 | 0.230 |
Why?
| | RNA-Binding Protein EWS | 1 | 2025 | 31 | 0.230 |
Why?
| | Thoracic Neoplasms | 1 | 2026 | 39 | 0.230 |
Why?
| | Neurofibroma, Plexiform | 1 | 2025 | 12 | 0.230 |
Why?
| | Metals | 4 | 1999 | 136 | 0.230 |
Why?
| | National Institutes of Health (U.S.) | 3 | 2018 | 147 | 0.230 |
Why?
| | Respiratory System | 2 | 2021 | 150 | 0.220 |
Why?
| | Teaching | 1 | 2008 | 237 | 0.220 |
Why?
| | Mesothelioma | 1 | 2026 | 51 | 0.220 |
Why?
| | NFATC Transcription Factors | 1 | 2025 | 94 | 0.220 |
Why?
| | Disease Susceptibility | 3 | 2018 | 344 | 0.220 |
Why?
| | Food Supply | 1 | 2026 | 85 | 0.220 |
Why?
| | Anemia | 1 | 2007 | 191 | 0.220 |
Why?
| | Bayes Theorem | 5 | 2006 | 420 | 0.220 |
Why?
| | Retrospective Studies | 13 | 2025 | 17291 | 0.220 |
Why?
| | Soft Tissue Infections | 1 | 2025 | 40 | 0.220 |
Why?
| | Neurofibromatosis 1 | 1 | 2025 | 55 | 0.220 |
Why?
| | Program Evaluation | 3 | 2020 | 943 | 0.220 |
Why?
| | Sacroiliac Joint | 1 | 2025 | 37 | 0.220 |
Why?
| | Epidemiologic Research Design | 3 | 2004 | 29 | 0.210 |
Why?
| | Radiography, Thoracic | 1 | 2006 | 172 | 0.210 |
Why?
| | Infant | 16 | 2016 | 10077 | 0.210 |
Why?
| | Myocardial Infarction | 1 | 2012 | 1210 | 0.210 |
Why?
| | Laryngeal Neoplasms | 2 | 2004 | 36 | 0.210 |
Why?
| | Age Distribution | 5 | 2013 | 403 | 0.210 |
Why?
| | Airports | 1 | 2024 | 3 | 0.210 |
Why?
| | Lactoferrin | 3 | 1999 | 36 | 0.210 |
Why?
| | Health Services Research | 2 | 2014 | 391 | 0.210 |
Why?
| | Mutagens | 1 | 2004 | 27 | 0.210 |
Why?
| | Hepatitis B | 1 | 2004 | 66 | 0.210 |
Why?
| | Infant, Newborn | 15 | 2016 | 6447 | 0.200 |
Why?
| | Health Personnel | 3 | 2022 | 754 | 0.200 |
Why?
| | Radiation, Ionizing | 1 | 2024 | 86 | 0.200 |
Why?
| | Rhinovirus | 1 | 2004 | 60 | 0.200 |
Why?
| | Epidemiological Monitoring | 7 | 2008 | 69 | 0.200 |
Why?
| | Mortality, Premature | 2 | 2024 | 15 | 0.200 |
Why?
| | National Health Programs | 2 | 2019 | 23 | 0.200 |
Why?
| | Cleft Palate | 2 | 2015 | 91 | 0.200 |
Why?
| | Glycerol | 1 | 2024 | 90 | 0.200 |
Why?
| | Oncogene Proteins, Fusion | 1 | 2025 | 212 | 0.200 |
Why?
| | Cross-Sectional Studies | 18 | 2024 | 5904 | 0.200 |
Why?
| | Time | 2 | 2003 | 84 | 0.200 |
Why?
| | Vulnerable Populations | 2 | 2015 | 176 | 0.200 |
Why?
| | Environment Design | 1 | 2003 | 27 | 0.200 |
Why?
| | Medical Marijuana | 1 | 2025 | 122 | 0.200 |
Why?
| | Liability, Legal | 2 | 2006 | 42 | 0.200 |
Why?
| | Hypertension | 5 | 2012 | 1273 | 0.190 |
Why?
| | Sarcoma | 1 | 2026 | 207 | 0.190 |
Why?
| | Pregnancy | 11 | 2016 | 7202 | 0.190 |
Why?
| | Osteomyelitis | 1 | 2025 | 145 | 0.190 |
Why?
| | Logistic Models | 10 | 2016 | 2134 | 0.190 |
Why?
| | Brain Neoplasms | 2 | 2010 | 1329 | 0.190 |
Why?
| | Dust | 4 | 2007 | 92 | 0.190 |
Why?
| | Germ-Line Mutation | 1 | 2004 | 176 | 0.190 |
Why?
| | Diabetes Complications | 1 | 2005 | 224 | 0.190 |
Why?
| | Fasting | 1 | 2005 | 279 | 0.190 |
Why?
| | Sensitivity and Specificity | 4 | 2016 | 1997 | 0.190 |
Why?
| | Travel | 1 | 2004 | 136 | 0.190 |
Why?
| | Weather | 5 | 2009 | 43 | 0.190 |
Why?
| | Medical Oncology | 1 | 2026 | 339 | 0.190 |
Why?
| | Disinfection | 1 | 2024 | 131 | 0.190 |
Why?
| | Databases as Topic | 4 | 2008 | 71 | 0.180 |
Why?
| | Reproducibility of Results | 6 | 2025 | 3413 | 0.180 |
Why?
| | Polonium | 3 | 1991 | 3 | 0.180 |
Why?
| | Electromagnetic Fields | 2 | 2014 | 37 | 0.180 |
Why?
| | Financial Support | 2 | 2016 | 18 | 0.180 |
Why?
| | Adrenal Cortex Hormones | 1 | 2005 | 484 | 0.180 |
Why?
| | Risk Management | 3 | 2008 | 82 | 0.180 |
Why?
| | California | 5 | 2025 | 471 | 0.180 |
Why?
| | Engineering | 1 | 2022 | 31 | 0.180 |
Why?
| | Pfiesteria piscicida | 1 | 2001 | 1 | 0.180 |
Why?
| | Protozoan Infections | 1 | 2001 | 11 | 0.180 |
Why?
| | Nickel | 4 | 2009 | 62 | 0.180 |
Why?
| | Healthcare Disparities | 2 | 2020 | 735 | 0.170 |
Why?
| | Shoulder Joint | 1 | 2024 | 199 | 0.170 |
Why?
| | Analgesics | 1 | 2023 | 231 | 0.170 |
Why?
| | Recurrence | 2 | 2019 | 1138 | 0.170 |
Why?
| | Policy Making | 4 | 2012 | 83 | 0.170 |
Why?
| | Lumbosacral Plexus | 1 | 2021 | 10 | 0.170 |
Why?
| | Estrogen Replacement Therapy | 1 | 2002 | 143 | 0.170 |
Why?
| | Baltimore | 5 | 2014 | 72 | 0.170 |
Why?
| | Gases | 2 | 2007 | 46 | 0.170 |
Why?
| | Pulmonary Fibrosis | 3 | 2000 | 395 | 0.170 |
Why?
| | Plants, Toxic | 2 | 1998 | 18 | 0.170 |
Why?
| | Maximum Allowable Concentration | 2 | 2015 | 16 | 0.170 |
Why?
| | Conflict of Interest | 1 | 2001 | 54 | 0.170 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2004 | 372 | 0.160 |
Why?
| | Residence Characteristics | 4 | 2018 | 375 | 0.160 |
Why?
| | Hyperglycemia | 1 | 2005 | 379 | 0.160 |
Why?
| | Reproduction | 2 | 2001 | 208 | 0.160 |
Why?
| | SEER Program | 2 | 2021 | 229 | 0.160 |
Why?
| | Bismuth | 2 | 1991 | 3 | 0.160 |
Why?
| | Receptors, Cell Surface | 2 | 2001 | 372 | 0.160 |
Why?
| | Extremities | 3 | 2024 | 141 | 0.160 |
Why?
| | Biodiversity | 1 | 2023 | 311 | 0.160 |
Why?
| | Patient Admission | 3 | 2012 | 220 | 0.160 |
Why?
| | Medicine | 1 | 2022 | 125 | 0.160 |
Why?
| | Poisson Distribution | 3 | 2012 | 78 | 0.150 |
Why?
| | Confidentiality | 2 | 2019 | 80 | 0.150 |
Why?
| | Algorithms | 6 | 2026 | 1845 | 0.150 |
Why?
| | Health Priorities | 4 | 2010 | 41 | 0.150 |
Why?
| | Social Determinants of Health | 1 | 2024 | 308 | 0.150 |
Why?
| | Clinical Medicine | 1 | 2000 | 26 | 0.150 |
Why?
| | Carbon | 5 | 2009 | 176 | 0.150 |
Why?
| | Competency-Based Education | 1 | 2020 | 81 | 0.150 |
Why?
| | Arachidonic Acid | 3 | 2001 | 102 | 0.150 |
Why?
| | Panama | 1 | 2019 | 11 | 0.150 |
Why?
| | Minnesota | 3 | 2009 | 168 | 0.150 |
Why?
| | Follow-Up Studies | 10 | 2020 | 5423 | 0.150 |
Why?
| | Anti-Inflammatory Agents | 1 | 2003 | 477 | 0.150 |
Why?
| | Talc | 1 | 2019 | 9 | 0.150 |
Why?
| | Petroleum Pollution | 1 | 2019 | 10 | 0.150 |
Why?
| | Public Health Surveillance | 1 | 2020 | 83 | 0.150 |
Why?
| | Models, Theoretical | 5 | 2014 | 558 | 0.150 |
Why?
| | Policy | 2 | 2021 | 148 | 0.150 |
Why?
| | Animals | 18 | 2020 | 38030 | 0.150 |
Why?
| | Mast Cells | 2 | 2001 | 147 | 0.150 |
Why?
| | Licensure | 1 | 2019 | 16 | 0.140 |
Why?
| | Peripheral Nerve Injuries | 1 | 2019 | 38 | 0.140 |
Why?
| | Ethiopia | 3 | 2026 | 44 | 0.140 |
Why?
| | Authorship | 1 | 1999 | 49 | 0.140 |
Why?
| | Arsenic | 1 | 1999 | 65 | 0.140 |
Why?
| | Catholicism | 1 | 2018 | 9 | 0.140 |
Why?
| | Artificial Intelligence | 1 | 2023 | 381 | 0.140 |
Why?
| | Molecular Epidemiology | 2 | 2009 | 73 | 0.140 |
Why?
| | Disasters | 3 | 2018 | 100 | 0.140 |
Why?
| | Mental Health | 1 | 2025 | 793 | 0.140 |
Why?
| | Weight Gain | 1 | 2002 | 561 | 0.140 |
Why?
| | Human Migration | 1 | 2018 | 25 | 0.140 |
Why?
| | Models, Biological | 4 | 2015 | 1764 | 0.140 |
Why?
| | Social Responsibility | 1 | 2018 | 53 | 0.140 |
Why?
| | Transferrin | 1 | 1998 | 50 | 0.140 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 1999 | 167 | 0.140 |
Why?
| | Greenhouse Gases | 1 | 2018 | 8 | 0.140 |
Why?
| | Glycine | 1 | 2019 | 186 | 0.140 |
Why?
| | Liver Neoplasms | 1 | 2004 | 776 | 0.140 |
Why?
| | HIV Infections | 5 | 2016 | 3193 | 0.140 |
Why?
| | Radiobiology | 1 | 2017 | 7 | 0.130 |
Why?
| | Frail Elderly | 1 | 1999 | 136 | 0.130 |
Why?
| | Poverty | 3 | 2023 | 526 | 0.130 |
Why?
| | Health Communication | 1 | 2018 | 53 | 0.130 |
Why?
| | Writing | 1 | 1999 | 101 | 0.130 |
Why?
| | Restaurants | 3 | 2012 | 22 | 0.130 |
Why?
| | Emergency Service, Hospital | 2 | 2009 | 2381 | 0.130 |
Why?
| | Veterans | 1 | 2010 | 1635 | 0.130 |
Why?
| | Antioxidants | 1 | 2001 | 550 | 0.130 |
Why?
| | Sleep | 3 | 2018 | 888 | 0.130 |
Why?
| | Cross-Over Studies | 4 | 2022 | 608 | 0.130 |
Why?
| | Ferritins | 4 | 1998 | 70 | 0.130 |
Why?
| | Industry | 2 | 2010 | 42 | 0.130 |
Why?
| | Cross-Cultural Comparison | 3 | 1994 | 84 | 0.130 |
Why?
| | Heating | 3 | 2007 | 18 | 0.130 |
Why?
| | Pulmonary Medicine | 2 | 2017 | 78 | 0.130 |
Why?
| | Betacoronavirus | 1 | 2020 | 288 | 0.130 |
Why?
| | Bronchitis, Chronic | 1 | 2017 | 16 | 0.130 |
Why?
| | Public Health Administration | 1 | 2018 | 70 | 0.130 |
Why?
| | Air | 2 | 2010 | 44 | 0.130 |
Why?
| | Economics | 1 | 2017 | 11 | 0.130 |
Why?
| | Imaging, Three-Dimensional | 1 | 2021 | 583 | 0.130 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2022 | 2588 | 0.130 |
Why?
| | Environment | 2 | 2012 | 293 | 0.120 |
Why?
| | Universities | 2 | 2016 | 445 | 0.120 |
Why?
| | Social Class | 3 | 2017 | 264 | 0.120 |
Why?
| | Publication Bias | 2 | 2008 | 18 | 0.120 |
Why?
| | Periodicals as Topic | 1 | 1999 | 209 | 0.120 |
Why?
| | Radiation Dosage | 4 | 2007 | 193 | 0.120 |
Why?
| | Occupational Health | 1 | 1999 | 211 | 0.120 |
Why?
| | Dioxins | 1 | 1996 | 7 | 0.120 |
Why?
| | Stem Cell Factor | 1 | 1996 | 16 | 0.120 |
Why?
| | Ferric Compounds | 1 | 1997 | 54 | 0.120 |
Why?
| | Iran | 1 | 2016 | 44 | 0.120 |
Why?
| | North America | 4 | 2021 | 302 | 0.120 |
Why?
| | Zinc | 1 | 1999 | 306 | 0.120 |
Why?
| | Peer Influence | 1 | 2016 | 14 | 0.120 |
Why?
| | Mental Disorders | 1 | 2025 | 1163 | 0.120 |
Why?
| | Product Labeling | 1 | 2016 | 11 | 0.120 |
Why?
| | Eating | 1 | 2018 | 387 | 0.120 |
Why?
| | Xenobiotics | 1 | 1995 | 30 | 0.120 |
Why?
| | Polycyclic Aromatic Hydrocarbons | 2 | 2007 | 27 | 0.120 |
Why?
| | Capacity Building | 1 | 2016 | 62 | 0.110 |
Why?
| | Socioeconomic Factors | 5 | 2016 | 1323 | 0.110 |
Why?
| | Emigrants and Immigrants | 1 | 2018 | 157 | 0.110 |
Why?
| | Air Pollution, Radioactive | 1 | 1994 | 2 | 0.110 |
Why?
| | Asia | 4 | 2024 | 70 | 0.110 |
Why?
| | Polychlorinated Dibenzodioxins | 2 | 2010 | 10 | 0.110 |
Why?
| | Motivation | 1 | 2020 | 600 | 0.110 |
Why?
| | Internationality | 1 | 2016 | 156 | 0.110 |
Why?
| | Coinfection | 1 | 2016 | 143 | 0.110 |
Why?
| | Cooking | 2 | 2023 | 57 | 0.110 |
Why?
| | Sleep Apnea, Obstructive | 2 | 2014 | 302 | 0.110 |
Why?
| | Schools, Medical | 1 | 2016 | 159 | 0.110 |
Why?
| | Primary Health Care | 1 | 2005 | 1735 | 0.110 |
Why?
| | Radiation Effects | 2 | 2004 | 7 | 0.110 |
Why?
| | Insurance, Health | 2 | 2009 | 310 | 0.110 |
Why?
| | Prognosis | 7 | 2025 | 4316 | 0.110 |
Why?
| | Oxidants | 1 | 1994 | 99 | 0.110 |
Why?
| | Latin America | 1 | 2014 | 96 | 0.100 |
Why?
| | PubMed | 1 | 2014 | 15 | 0.100 |
Why?
| | Temperature | 5 | 2005 | 633 | 0.100 |
Why?
| | Review Literature as Topic | 1 | 2014 | 52 | 0.100 |
Why?
| | Mastectomy, Segmental | 1 | 1994 | 107 | 0.100 |
Why?
| | Pelvic Bones | 1 | 2016 | 134 | 0.100 |
Why?
| | Silicosis | 1 | 1994 | 30 | 0.100 |
Why?
| | Ganglionic Stimulants | 2 | 2015 | 15 | 0.100 |
Why?
| | Cleft Lip | 1 | 2014 | 73 | 0.100 |
Why?
| | Mucus | 1 | 1994 | 75 | 0.100 |
Why?
| | Drug Synergism | 1 | 2014 | 354 | 0.100 |
Why?
| | Health Plan Implementation | 1 | 2014 | 141 | 0.100 |
Why?
| | Breast | 1 | 1994 | 156 | 0.100 |
Why?
| | Analysis of Variance | 4 | 2009 | 1300 | 0.100 |
Why?
| | Community Networks | 1 | 2013 | 57 | 0.100 |
Why?
| | Benzene | 2 | 2023 | 18 | 0.100 |
Why?
| | Bone and Bones | 1 | 2016 | 317 | 0.100 |
Why?
| | Taxes | 2 | 2010 | 16 | 0.100 |
Why?
| | History, 19th Century | 1 | 2013 | 63 | 0.100 |
Why?
| | Administration, Inhalation | 2 | 2005 | 571 | 0.090 |
Why?
| | Greenhouse Effect | 3 | 2001 | 7 | 0.090 |
Why?
| | American Cancer Society | 2 | 2009 | 7 | 0.090 |
Why?
| | Zonula Occludens-1 Protein | 1 | 2012 | 17 | 0.090 |
Why?
| | Names | 1 | 2012 | 15 | 0.090 |
Why?
| | Apoptosis Regulatory Proteins | 2 | 2024 | 187 | 0.090 |
Why?
| | Iron | 4 | 1999 | 357 | 0.090 |
Why?
| | Snoring | 2 | 2010 | 19 | 0.090 |
Why?
| | Local Government | 1 | 2012 | 28 | 0.090 |
Why?
| | Allergens | 2 | 2014 | 386 | 0.090 |
Why?
| | Calpain | 1 | 2012 | 61 | 0.090 |
Why?
| | Program Development | 1 | 2014 | 368 | 0.090 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2021 | 1189 | 0.090 |
Why?
| | Inflammation | 4 | 2023 | 2878 | 0.090 |
Why?
| | Sodium, Dietary | 1 | 2012 | 42 | 0.090 |
Why?
| | United Kingdom | 2 | 2006 | 344 | 0.090 |
Why?
| | Nonlinear Dynamics | 2 | 2003 | 92 | 0.090 |
Why?
| | TRPM Cation Channels | 1 | 2012 | 73 | 0.090 |
Why?
| | Feeding Behavior | 1 | 1998 | 690 | 0.090 |
Why?
| | Sampling Studies | 2 | 2006 | 98 | 0.090 |
Why?
| | Diet, Carbohydrate-Restricted | 2 | 2022 | 38 | 0.090 |
Why?
| | Public Facilities | 2 | 2008 | 3 | 0.090 |
Why?
| | Eosinophils | 1 | 2014 | 316 | 0.090 |
Why?
| | Maryland | 2 | 2008 | 67 | 0.090 |
Why?
| | Pennsylvania | 5 | 2006 | 138 | 0.080 |
Why?
| | Sick Building Syndrome | 1 | 2011 | 4 | 0.080 |
Why?
| | Students, Medical | 1 | 2016 | 378 | 0.080 |
Why?
| | Body Temperature | 2 | 2002 | 227 | 0.080 |
Why?
| | Communicable Diseases | 2 | 2011 | 166 | 0.080 |
Why?
| | Crime | 1 | 2011 | 57 | 0.080 |
Why?
| | Printing | 1 | 2010 | 5 | 0.080 |
Why?
| | Health Education | 4 | 2014 | 346 | 0.080 |
Why?
| | Manufactured Materials | 1 | 2010 | 9 | 0.080 |
Why?
| | Self Report | 4 | 2017 | 870 | 0.080 |
Why?
| | Cell Line, Transformed | 3 | 1999 | 138 | 0.080 |
Why?
| | Pregnancy, Ectopic | 1 | 1991 | 54 | 0.080 |
Why?
| | Defoliants, Chemical | 1 | 2010 | 2 | 0.080 |
Why?
| | Prostatic Neoplasms | 3 | 1996 | 978 | 0.080 |
Why?
| | Agent Orange | 1 | 2010 | 3 | 0.080 |
Why?
| | 2,4,5-Trichlorophenoxyacetic Acid | 1 | 2010 | 3 | 0.080 |
Why?
| | Maternal Welfare | 1 | 2010 | 22 | 0.080 |
Why?
| | 2,4-Dichlorophenoxyacetic Acid | 1 | 2010 | 14 | 0.080 |
Why?
| | Aging | 2 | 2002 | 1969 | 0.080 |
Why?
| | Lung Diseases, Obstructive | 2 | 1988 | 43 | 0.080 |
Why?
| | Waist Circumference | 1 | 2010 | 143 | 0.080 |
Why?
| | New York City | 2 | 2007 | 84 | 0.080 |
Why?
| | Water Pollution | 2 | 2018 | 7 | 0.080 |
Why?
| | Developed Countries | 1 | 2010 | 38 | 0.080 |
Why?
| | Disclosure | 1 | 2010 | 84 | 0.080 |
Why?
| | Curriculum | 2 | 2008 | 1070 | 0.080 |
Why?
| | Suicide | 1 | 2017 | 728 | 0.080 |
Why?
| | Legislation as Topic | 1 | 2009 | 5 | 0.080 |
Why?
| | Carcinoma | 2 | 2007 | 225 | 0.080 |
Why?
| | Legislation, Medical | 1 | 2009 | 11 | 0.070 |
Why?
| | Radioactive Pollutants | 1 | 1989 | 1 | 0.070 |
Why?
| | Medical Record Linkage | 2 | 2013 | 68 | 0.070 |
Why?
| | Monte Carlo Method | 1 | 2009 | 147 | 0.070 |
Why?
| | Food Contamination, Radioactive | 1 | 1989 | 1 | 0.070 |
Why?
| | Birth Weight | 1 | 2012 | 514 | 0.070 |
Why?
| | Models, Econometric | 1 | 2009 | 34 | 0.070 |
Why?
| | Cooperative Behavior | 2 | 2018 | 462 | 0.070 |
Why?
| | Radioisotopes | 1 | 1989 | 37 | 0.070 |
Why?
| | Survival Rate | 5 | 2009 | 2090 | 0.070 |
Why?
| | Costs and Cost Analysis | 1 | 2010 | 221 | 0.070 |
Why?
| | Phospholipases A | 2 | 2001 | 97 | 0.070 |
Why?
| | Gallbladder Diseases | 1 | 1988 | 11 | 0.070 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2009 | 124 | 0.070 |
Why?
| | New York | 2 | 2010 | 128 | 0.070 |
Why?
| | ROC Curve | 1 | 2010 | 617 | 0.070 |
Why?
| | Nicotinic Antagonists | 1 | 2008 | 36 | 0.070 |
Why?
| | Decision Making | 3 | 2010 | 977 | 0.070 |
Why?
| | Epithelial Cells | 6 | 2000 | 1131 | 0.070 |
Why?
| | Computer Simulation | 2 | 2009 | 1003 | 0.070 |
Why?
| | Interdisciplinary Communication | 2 | 2011 | 200 | 0.070 |
Why?
| | Students, Public Health | 1 | 2008 | 1 | 0.070 |
Why?
| | Dyspnea | 3 | 2024 | 250 | 0.070 |
Why?
| | Nutrition Surveys | 2 | 2012 | 279 | 0.070 |
Why?
| | DNA Damage | 2 | 2004 | 437 | 0.070 |
Why?
| | Cells, Cultured | 6 | 2012 | 4148 | 0.070 |
Why?
| | Signal Transduction | 3 | 2003 | 5216 | 0.070 |
Why?
| | Epidemiologic Factors | 2 | 2002 | 10 | 0.070 |
Why?
| | Bone Marrow Cells | 2 | 2001 | 321 | 0.070 |
Why?
| | Bronchial Hyperreactivity | 1 | 2008 | 104 | 0.070 |
Why?
| | Spectroscopy, Fourier Transform Infrared | 1 | 2007 | 85 | 0.070 |
Why?
| | Agriculture | 2 | 2026 | 94 | 0.060 |
Why?
| | Coal Ash | 4 | 2000 | 8 | 0.060 |
Why?
| | Cardiovascular System | 1 | 2009 | 138 | 0.060 |
Why?
| | Rescue Work | 1 | 2007 | 12 | 0.060 |
Why?
| | Financing, Government | 2 | 2004 | 53 | 0.060 |
Why?
| | Delivery of Health Care | 1 | 2014 | 946 | 0.060 |
Why?
| | Polysomnography | 5 | 2009 | 239 | 0.060 |
Why?
| | Predictive Value of Tests | 3 | 2010 | 2121 | 0.060 |
Why?
| | Pregnancy Outcome | 1 | 1991 | 503 | 0.060 |
Why?
| | Menopause | 2 | 2002 | 326 | 0.060 |
Why?
| | Automobile Driving | 1 | 2009 | 157 | 0.060 |
Why?
| | Overweight | 2 | 2016 | 614 | 0.060 |
Why?
| | Genome-Wide Association Study | 2 | 2014 | 1407 | 0.060 |
Why?
| | Insurance Coverage | 1 | 2009 | 244 | 0.060 |
Why?
| | Tars | 1 | 2006 | 5 | 0.060 |
Why?
| | Forced Expiratory Volume | 3 | 2016 | 450 | 0.060 |
Why?
| | Schools, Public Health | 1 | 2006 | 4 | 0.060 |
Why?
| | Poland | 1 | 2006 | 34 | 0.060 |
Why?
| | Chromatography, Gas | 1 | 2006 | 30 | 0.060 |
Why?
| | Multivariate Analysis | 5 | 2009 | 1547 | 0.060 |
Why?
| | Geography | 2 | 2008 | 187 | 0.060 |
Why?
| | NF-kappa B | 3 | 2001 | 666 | 0.060 |
Why?
| | Cost-Benefit Analysis | 1 | 2009 | 639 | 0.060 |
Why?
| | Energy Intake | 2 | 2001 | 512 | 0.060 |
Why?
| | Biomass | 1 | 2007 | 96 | 0.060 |
Why?
| | Quality Improvement | 1 | 2015 | 1295 | 0.060 |
Why?
| | Cattle | 1 | 1989 | 946 | 0.060 |
Why?
| | Survival Analysis | 2 | 2004 | 1374 | 0.060 |
Why?
| | Fires | 1 | 2007 | 77 | 0.060 |
Why?
| | Sulfur Dioxide | 4 | 2001 | 12 | 0.060 |
Why?
| | Consensus | 1 | 2008 | 477 | 0.060 |
Why?
| | Single Person | 1 | 1986 | 6 | 0.060 |
Why?
| | Practice Guidelines as Topic | 3 | 2017 | 1581 | 0.060 |
Why?
| | Africa, Eastern | 1 | 2026 | 12 | 0.060 |
Why?
| | Statistics, Nonparametric | 2 | 2009 | 428 | 0.060 |
Why?
| | Cough | 1 | 2007 | 124 | 0.060 |
Why?
| | Population Growth | 1 | 2026 | 12 | 0.060 |
Why?
| | Gift Giving | 1 | 2006 | 9 | 0.060 |
Why?
| | Students | 3 | 2016 | 651 | 0.060 |
Why?
| | Sleep Stages | 1 | 2006 | 76 | 0.060 |
Why?
| | ErbB Receptors | 1 | 2009 | 635 | 0.060 |
Why?
| | Models, Educational | 1 | 2006 | 90 | 0.060 |
Why?
| | Computer-Assisted Instruction | 1 | 2006 | 70 | 0.060 |
Why?
| | Health Status | 2 | 2020 | 832 | 0.060 |
Why?
| | Edible Grain | 1 | 2026 | 47 | 0.060 |
Why?
| | Thinness | 1 | 2006 | 100 | 0.060 |
Why?
| | Interinstitutional Relations | 1 | 2006 | 55 | 0.060 |
Why?
| | Meta-Analysis as Topic | 1 | 2006 | 171 | 0.060 |
Why?
| | Bioterrorism | 1 | 2006 | 31 | 0.060 |
Why?
| | Biological Specimen Banks | 1 | 2006 | 109 | 0.060 |
Why?
| | Peripheral Arterial Disease | 1 | 2012 | 507 | 0.060 |
Why?
| | Endothelium, Vascular | 1 | 2012 | 956 | 0.060 |
Why?
| | Behavior, Addictive | 1 | 2006 | 88 | 0.060 |
Why?
| | Education, Distance | 1 | 2006 | 59 | 0.060 |
Why?
| | United States Department of Veterans Affairs | 1 | 2010 | 778 | 0.060 |
Why?
| | Rats | 4 | 1998 | 5584 | 0.060 |
Why?
| | Communicable Disease Control | 1 | 2006 | 85 | 0.060 |
Why?
| | Goals | 1 | 2007 | 184 | 0.050 |
Why?
| | Hepatitis B Surface Antigens | 1 | 2004 | 17 | 0.050 |
Why?
| | Interviews as Topic | 4 | 2010 | 910 | 0.050 |
Why?
| | Deferoxamine | 3 | 1999 | 27 | 0.050 |
Why?
| | Immunohistochemistry | 2 | 1999 | 1716 | 0.050 |
Why?
| | Financing, Organized | 1 | 2004 | 36 | 0.050 |
Why?
| | Uruguay | 1 | 2004 | 2 | 0.050 |
Why?
| | Paraguay | 1 | 2004 | 3 | 0.050 |
Why?
| | Mexican Americans | 2 | 2018 | 119 | 0.050 |
Why?
| | Longitudinal Studies | 3 | 2016 | 2953 | 0.050 |
Why?
| | Carcinoma, Squamous Cell | 3 | 2015 | 641 | 0.050 |
Why?
| | Costa Rica | 1 | 2004 | 18 | 0.050 |
Why?
| | Glomerular Filtration Rate | 1 | 2008 | 765 | 0.050 |
Why?
| | Disaster Planning | 1 | 2006 | 103 | 0.050 |
Why?
| | Argentina | 1 | 2004 | 30 | 0.050 |
Why?
| | Spermatogonia | 1 | 2004 | 16 | 0.050 |
Why?
| | Observer Variation | 1 | 2025 | 357 | 0.050 |
Why?
| | Chile | 1 | 2004 | 27 | 0.050 |
Why?
| | Diet Surveys | 1 | 1984 | 90 | 0.050 |
Why?
| | Stroke | 1 | 2013 | 1270 | 0.050 |
Why?
| | Tandem Repeat Sequences | 1 | 2004 | 23 | 0.050 |
Why?
| | No-Observed-Adverse-Effect Level | 1 | 2004 | 7 | 0.050 |
Why?
| | Diet | 4 | 2003 | 1277 | 0.050 |
Why?
| | Peru | 1 | 2004 | 60 | 0.050 |
Why?
| | Picornaviridae | 1 | 2004 | 18 | 0.050 |
Why?
| | Bronchodilator Agents | 1 | 2005 | 187 | 0.050 |
Why?
| | Uganda | 1 | 2024 | 89 | 0.050 |
Why?
| | Mentors | 2 | 2003 | 217 | 0.050 |
Why?
| | Aircraft | 1 | 2004 | 22 | 0.050 |
Why?
| | Nose Diseases | 1 | 2004 | 17 | 0.050 |
Why?
| | Shoulder Pain | 1 | 2024 | 36 | 0.050 |
Why?
| | Electroencephalography | 1 | 2007 | 561 | 0.050 |
Why?
| | Clinical Trials, Phase II as Topic | 1 | 2004 | 75 | 0.050 |
Why?
| | Propylene Glycols | 1 | 2024 | 28 | 0.050 |
Why?
| | Aerospace Medicine | 1 | 2004 | 32 | 0.050 |
Why?
| | Ear Diseases | 1 | 2004 | 20 | 0.050 |
Why?
| | Sugars | 1 | 2024 | 40 | 0.050 |
Why?
| | Picornaviridae Infections | 1 | 2004 | 53 | 0.050 |
Why?
| | Saskatchewan | 1 | 2003 | 8 | 0.050 |
Why?
| | Shoulder | 1 | 2024 | 105 | 0.050 |
Why?
| | Nasal Mucosa | 1 | 2004 | 112 | 0.050 |
Why?
| | Fourier Analysis | 1 | 2003 | 42 | 0.050 |
Why?
| | Observation | 1 | 2003 | 54 | 0.050 |
Why?
| | Food | 1 | 1984 | 150 | 0.050 |
Why?
| | Chicago | 1 | 2003 | 62 | 0.050 |
Why?
| | Probability | 2 | 2003 | 307 | 0.050 |
Why?
| | Wakefulness | 1 | 2004 | 170 | 0.050 |
Why?
| | Free Radical Scavengers | 4 | 2012 | 82 | 0.050 |
Why?
| | Computing Methodologies | 1 | 2003 | 3 | 0.050 |
Why?
| | Maps as Topic | 1 | 2003 | 5 | 0.050 |
Why?
| | Phosphotyrosine | 2 | 2000 | 38 | 0.050 |
Why?
| | Decision Support Techniques | 1 | 2008 | 477 | 0.050 |
Why?
| | Coroners and Medical Examiners | 1 | 2022 | 8 | 0.050 |
Why?
| | Maternal-Fetal Exchange | 2 | 2015 | 170 | 0.050 |
Why?
| | Washington | 1 | 2003 | 149 | 0.050 |
Why?
| | Efficiency | 1 | 2003 | 103 | 0.050 |
Why?
| | Genomics | 1 | 2008 | 825 | 0.050 |
Why?
| | Terminology as Topic | 1 | 1985 | 257 | 0.050 |
Why?
| | Geographic Information Systems | 1 | 2003 | 45 | 0.050 |
Why?
| | Neoplasm Staging | 2 | 2021 | 1471 | 0.050 |
Why?
| | Income | 2 | 1994 | 202 | 0.050 |
Why?
| | Body Constitution | 1 | 2002 | 51 | 0.050 |
Why?
| | Steroids | 1 | 2003 | 160 | 0.050 |
Why?
| | Carbon Dioxide | 1 | 2004 | 227 | 0.050 |
Why?
| | Nitrosamines | 2 | 2012 | 9 | 0.050 |
Why?
| | Sleep Wake Disorders | 1 | 2006 | 314 | 0.040 |
Why?
| | Macrophages, Alveolar | 2 | 1997 | 373 | 0.040 |
Why?
| | Chi-Square Distribution | 2 | 2006 | 527 | 0.040 |
Why?
| | Epidemiologic Measurements | 1 | 2001 | 1 | 0.040 |
Why?
| | Peer Group | 1 | 2004 | 253 | 0.040 |
Why?
| | Toxins, Biological | 1 | 2001 | 12 | 0.040 |
Why?
| | Joint Instability | 1 | 2024 | 183 | 0.040 |
Why?
| | Chelating Agents | 2 | 1999 | 76 | 0.040 |
Why?
| | Invertebrates | 1 | 2001 | 21 | 0.040 |
Why?
| | Internet | 1 | 2006 | 689 | 0.040 |
Why?
| | France | 1 | 2021 | 40 | 0.040 |
Why?
| | Philadelphia | 2 | 1998 | 55 | 0.040 |
Why?
| | Sinusitis | 1 | 2004 | 227 | 0.040 |
Why?
| | Schizophrenia | 1 | 2025 | 453 | 0.040 |
Why?
| | Likelihood Functions | 1 | 2001 | 138 | 0.040 |
Why?
| | Vitamin A | 3 | 1987 | 60 | 0.040 |
Why?
| | Patient Acceptance of Health Care | 1 | 1988 | 881 | 0.040 |
Why?
| | Food Chain | 1 | 2001 | 36 | 0.040 |
Why?
| | Fishes | 1 | 2001 | 109 | 0.040 |
Why?
| | Germany | 1 | 2021 | 138 | 0.040 |
Why?
| | Treatment Outcome | 2 | 2008 | 11772 | 0.040 |
Why?
| | C-Reactive Protein | 1 | 2023 | 422 | 0.040 |
Why?
| | Population Dynamics | 1 | 2001 | 142 | 0.040 |
Why?
| | Drug Administration Schedule | 1 | 2002 | 782 | 0.040 |
Why?
| | Pilot Projects | 1 | 2006 | 1891 | 0.040 |
Why?
| | Double-Blind Method | 2 | 2016 | 2062 | 0.040 |
Why?
| | Receptors, Progesterone | 1 | 2002 | 243 | 0.040 |
Why?
| | Postmenopause | 1 | 2002 | 392 | 0.040 |
Why?
| | Mathematics | 1 | 2000 | 101 | 0.040 |
Why?
| | Respiratory Hypersensitivity | 1 | 2000 | 65 | 0.040 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2010 | 1419 | 0.040 |
Why?
| | Stem Cells | 1 | 2004 | 628 | 0.040 |
Why?
| | Drug Interactions | 2 | 2003 | 405 | 0.040 |
Why?
| | Chromosome Deletion | 2 | 1997 | 126 | 0.040 |
Why?
| | Confidence Intervals | 3 | 2009 | 330 | 0.040 |
Why?
| | Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 1999 | 44 | 0.040 |
Why?
| | Protein Synthesis Inhibitors | 1 | 1999 | 48 | 0.040 |
Why?
| | Health Status Indicators | 2 | 2000 | 167 | 0.040 |
Why?
| | Smoking Water Pipes | 1 | 2019 | 9 | 0.040 |
Why?
| | Receptors, Estrogen | 1 | 2002 | 401 | 0.040 |
Why?
| | Culture Media | 1 | 1999 | 161 | 0.040 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2000 | 288 | 0.040 |
Why?
| | Religious Personnel | 1 | 2018 | 1 | 0.040 |
Why?
| | Bibliometrics | 1 | 1999 | 66 | 0.040 |
Why?
| | Infant, Low Birth Weight | 1 | 1999 | 156 | 0.040 |
Why?
| | Fossil Fuels | 2 | 2001 | 9 | 0.040 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 1998 | 638 | 0.040 |
Why?
| | Heart Rate | 1 | 2002 | 855 | 0.030 |
Why?
| | Acquired Immunodeficiency Syndrome | 1 | 2000 | 237 | 0.030 |
Why?
| | Activities of Daily Living | 2 | 1993 | 444 | 0.030 |
Why?
| | Maternal Age | 1 | 1998 | 128 | 0.030 |
Why?
| | Acculturation | 1 | 2018 | 55 | 0.030 |
Why?
| | Copper | 1 | 1998 | 119 | 0.030 |
Why?
| | Anthropometry | 1 | 2018 | 206 | 0.030 |
Why?
| | DNA Adducts | 1 | 1997 | 16 | 0.030 |
Why?
| | Benzo(a)pyrene | 1 | 1997 | 8 | 0.030 |
Why?
| | Mice | 4 | 2008 | 18329 | 0.030 |
Why?
| | Lactation | 1 | 1998 | 193 | 0.030 |
Why?
| | Arizona | 2 | 2006 | 80 | 0.030 |
Why?
| | Interleukin-6 | 2 | 1998 | 776 | 0.030 |
Why?
| | Clinical Competence | 1 | 2025 | 1243 | 0.030 |
Why?
| | Stakeholder Participation | 1 | 2018 | 84 | 0.030 |
Why?
| | National Heart, Lung, and Blood Institute (U.S.) | 1 | 2017 | 103 | 0.030 |
Why?
| | HIV Seronegativity | 1 | 1996 | 29 | 0.030 |
Why?
| | Injury Severity Score | 1 | 2019 | 599 | 0.030 |
Why?
| | Marriage | 3 | 1987 | 121 | 0.030 |
Why?
| | Multilevel Analysis | 1 | 2016 | 36 | 0.030 |
Why?
| | Weight Loss | 1 | 2022 | 858 | 0.030 |
Why?
| | Body Weight | 1 | 2021 | 971 | 0.030 |
Why?
| | Mice, Inbred CBA | 1 | 1996 | 57 | 0.030 |
Why?
| | Social Support | 2 | 1993 | 646 | 0.030 |
Why?
| | Chemical Industry | 1 | 1996 | 9 | 0.030 |
Why?
| | Phospholipases A2 | 1 | 1996 | 79 | 0.030 |
Why?
| | Silicon Dioxide | 1 | 1997 | 119 | 0.030 |
Why?
| | New Zealand | 1 | 2016 | 54 | 0.030 |
Why?
| | Head and Neck Neoplasms | 1 | 2001 | 561 | 0.030 |
Why?
| | Arachidonate 5-Lipoxygenase | 1 | 1996 | 37 | 0.030 |
Why?
| | Acetylcysteine | 2 | 2012 | 139 | 0.030 |
Why?
| | Needs Assessment | 1 | 1999 | 402 | 0.030 |
Why?
| | Multicenter Studies as Topic | 1 | 1998 | 412 | 0.030 |
Why?
| | Government Agencies | 1 | 1995 | 14 | 0.030 |
Why?
| | Eicosanoids | 1 | 1996 | 58 | 0.030 |
Why?
| | Patient Protection and Affordable Care Act | 1 | 2016 | 103 | 0.030 |
Why?
| | Genotype | 2 | 2014 | 1852 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2006 | 4560 | 0.030 |
Why?
| | Enzyme Inhibitors | 1 | 1999 | 820 | 0.030 |
Why?
| | Africa, Central | 1 | 2015 | 6 | 0.030 |
Why?
| | Indians, Central American | 1 | 2015 | 6 | 0.030 |
Why?
| | Asia, Southeastern | 1 | 2015 | 12 | 0.030 |
Why?
| | Central America | 1 | 2015 | 28 | 0.030 |
Why?
| | Indians, South American | 1 | 2015 | 23 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 2 | 1998 | 2524 | 0.030 |
Why?
| | Microscopy, Electron | 1 | 1996 | 414 | 0.030 |
Why?
| | South Africa | 1 | 2016 | 266 | 0.030 |
Why?
| | Educational Status | 2 | 1996 | 466 | 0.030 |
Why?
| | Demography | 2 | 2000 | 282 | 0.030 |
Why?
| | Neoplasms, Experimental | 1 | 1996 | 167 | 0.030 |
Why?
| | Carrier Proteins | 1 | 1999 | 728 | 0.030 |
Why?
| | Cell Transformation, Neoplastic | 1 | 1997 | 337 | 0.030 |
Why?
| | Random Allocation | 1 | 1995 | 365 | 0.030 |
Why?
| | Homosexuality, Male | 1 | 1996 | 231 | 0.030 |
Why?
| | Carbohydrate Sequence | 1 | 1994 | 29 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2021 | 1747 | 0.030 |
Why?
| | Cytokines | 2 | 2003 | 2067 | 0.030 |
Why?
| | Breast Feeding | 1 | 1998 | 446 | 0.030 |
Why?
| | Animals, Newborn | 1 | 1997 | 891 | 0.030 |
Why?
| | Small Cell Lung Carcinoma | 1 | 2015 | 122 | 0.030 |
Why?
| | Ecosystem | 1 | 2018 | 478 | 0.030 |
Why?
| | Population Density | 1 | 1994 | 89 | 0.030 |
Why?
| | Linkage Disequilibrium | 1 | 2014 | 253 | 0.030 |
Why?
| | Occupations | 2 | 2000 | 50 | 0.020 |
Why?
| | Hydrocarbons | 1 | 1993 | 29 | 0.020 |
Why?
| | Mental Competency | 1 | 1993 | 26 | 0.020 |
Why?
| | Patient Care Team | 1 | 1999 | 696 | 0.020 |
Why?
| | Ecology | 1 | 1994 | 105 | 0.020 |
Why?
| | Health Services Needs and Demand | 1 | 2015 | 280 | 0.020 |
Why?
| | Family Health | 1 | 1994 | 191 | 0.020 |
Why?
| | Fatty Acids | 1 | 1996 | 457 | 0.020 |
Why?
| | Membrane Proteins | 1 | 1999 | 1164 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 1996 | 1368 | 0.020 |
Why?
| | Vital Statistics | 1 | 1992 | 5 | 0.020 |
Why?
| | Transportation of Patients | 1 | 1993 | 65 | 0.020 |
Why?
| | Heart Failure | 1 | 2006 | 2326 | 0.020 |
Why?
| | Cadmium | 1 | 2012 | 68 | 0.020 |
Why?
| | Molecular Sequence Data | 2 | 1994 | 2883 | 0.020 |
Why?
| | Biopsy | 1 | 2015 | 1082 | 0.020 |
Why?
| | Electric Impedance | 1 | 2012 | 108 | 0.020 |
Why?
| | Permeability | 1 | 2012 | 169 | 0.020 |
Why?
| | Genes, p53 | 1 | 1992 | 67 | 0.020 |
Why?
| | Genes, ras | 1 | 1992 | 96 | 0.020 |
Why?
| | Physical Fitness | 1 | 1993 | 207 | 0.020 |
Why?
| | Africa | 1 | 2012 | 119 | 0.020 |
Why?
| | Drug Evaluation | 1 | 2011 | 79 | 0.020 |
Why?
| | Alleles | 1 | 2014 | 894 | 0.020 |
Why?
| | Sick Leave | 1 | 2011 | 16 | 0.020 |
Why?
| | Safety | 1 | 1993 | 358 | 0.020 |
Why?
| | Otitis Media | 1 | 1994 | 182 | 0.020 |
Why?
| | Colorado | 1 | 2021 | 4553 | 0.020 |
Why?
| | Recreation | 1 | 2011 | 29 | 0.020 |
Why?
| | Quality of Life | 1 | 2003 | 3204 | 0.020 |
Why?
| | Survivors | 2 | 2004 | 523 | 0.020 |
Why?
| | HIV-1 | 1 | 2016 | 908 | 0.020 |
Why?
| | Macrophages | 1 | 1998 | 1507 | 0.020 |
Why?
| | RNA, Messenger | 4 | 1998 | 2803 | 0.020 |
Why?
| | Dichlorodiphenyldichloroethane | 1 | 2009 | 1 | 0.020 |
Why?
| | Disease Progression | 1 | 1998 | 2864 | 0.020 |
Why?
| | Coffee | 1 | 2009 | 15 | 0.020 |
Why?
| | False Negative Reactions | 1 | 2009 | 61 | 0.020 |
Why?
| | Mass Media | 1 | 2010 | 39 | 0.020 |
Why?
| | Health Services | 1 | 1990 | 113 | 0.020 |
Why?
| | Reactive Oxygen Species | 1 | 2012 | 611 | 0.020 |
Why?
| | False Positive Reactions | 1 | 2009 | 123 | 0.020 |
Why?
| | Thorium | 1 | 1989 | 2 | 0.020 |
Why?
| | Ether | 1 | 2009 | 8 | 0.020 |
Why?
| | Radium | 1 | 1989 | 4 | 0.020 |
Why?
| | Metallurgy | 1 | 1989 | 9 | 0.020 |
Why?
| | Methylene Chloride | 1 | 2009 | 4 | 0.020 |
Why?
| | Early Detection of Cancer | 1 | 2014 | 485 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 1998 | 2597 | 0.020 |
Why?
| | Rectal Neoplasms | 1 | 1990 | 159 | 0.020 |
Why?
| | Colorectal Neoplasms | 2 | 1996 | 866 | 0.020 |
Why?
| | Culture | 1 | 2010 | 124 | 0.020 |
Why?
| | Neuropsychological Tests | 1 | 1993 | 1134 | 0.020 |
Why?
| | Lipid Metabolism | 1 | 1992 | 529 | 0.020 |
Why?
| | Taiwan | 1 | 2008 | 48 | 0.020 |
Why?
| | Death Certificates | 1 | 1988 | 32 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2016 | 2930 | 0.020 |
Why?
| | Pyridines | 1 | 2012 | 609 | 0.020 |
Why?
| | Cell Differentiation | 1 | 1996 | 2046 | 0.020 |
Why?
| | Secondary Prevention | 1 | 2010 | 251 | 0.020 |
Why?
| | Industrial Waste | 1 | 2008 | 5 | 0.020 |
Why?
| | Colonic Neoplasms | 1 | 1990 | 257 | 0.020 |
Why?
| | Liver | 1 | 1997 | 1896 | 0.020 |
Why?
| | Ovalbumin | 1 | 2008 | 194 | 0.020 |
Why?
| | Pregnancy Complications | 1 | 1994 | 602 | 0.020 |
Why?
| | Welding | 1 | 1987 | 2 | 0.020 |
Why?
| | Paint | 1 | 1987 | 8 | 0.020 |
Why?
| | Government Programs | 1 | 2008 | 27 | 0.020 |
Why?
| | Texas | 1 | 1988 | 272 | 0.020 |
Why?
| | Risk Reduction Behavior | 1 | 2009 | 217 | 0.020 |
Why?
| | Schools | 1 | 2011 | 448 | 0.020 |
Why?
| | Forced Expiratory Flow Rates | 1 | 1987 | 10 | 0.020 |
Why?
| | Peak Expiratory Flow Rate | 1 | 1987 | 25 | 0.020 |
Why?
| | Conservation of Energy Resources | 1 | 2007 | 3 | 0.020 |
Why?
| | Physical Examination | 1 | 1988 | 243 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2014 | 2158 | 0.020 |
Why?
| | Behavior Therapy | 1 | 2010 | 296 | 0.020 |
Why?
| | Calcium | 1 | 2012 | 1190 | 0.010 |
Why?
| | Radiation Monitoring | 1 | 1986 | 16 | 0.010 |
Why?
| | Attitude | 1 | 1988 | 259 | 0.010 |
Why?
| | Massachusetts | 1 | 2006 | 180 | 0.010 |
Why?
| | Air Conditioning | 1 | 2006 | 5 | 0.010 |
Why?
| | HIV | 1 | 2007 | 251 | 0.010 |
Why?
| | Medical History Taking | 1 | 1986 | 117 | 0.010 |
Why?
| | Arousal | 1 | 2006 | 157 | 0.010 |
Why?
| | Oxidative Stress | 1 | 2012 | 1356 | 0.010 |
Why?
| | Antiretroviral Therapy, Highly Active | 1 | 2007 | 279 | 0.010 |
Why?
| | Physicians | 1 | 1994 | 955 | 0.010 |
Why?
| | Statistics as Topic | 1 | 1986 | 283 | 0.010 |
Why?
| | Rural Population | 2 | 1987 | 659 | 0.010 |
Why?
| | Electronic Health Records | 1 | 2013 | 1196 | 0.010 |
Why?
| | beta Carotene | 1 | 1984 | 20 | 0.010 |
Why?
| | Carotenoids | 1 | 1984 | 47 | 0.010 |
Why?
| | Nitrogen Oxides | 1 | 2004 | 46 | 0.010 |
Why?
| | X-Rays | 1 | 2003 | 27 | 0.010 |
Why?
| | Dementia | 1 | 1988 | 327 | 0.010 |
Why?
| | Pneumoconiosis | 1 | 1984 | 20 | 0.010 |
Why?
| | Heart Conduction System | 1 | 2004 | 96 | 0.010 |
Why?
| | Biophysical Phenomena | 1 | 2003 | 67 | 0.010 |
Why?
| | Population | 1 | 2003 | 30 | 0.010 |
Why?
| | Gamma Rays | 1 | 2003 | 57 | 0.010 |
Why?
| | Biophysics | 1 | 2003 | 75 | 0.010 |
Why?
| | Oxyhemoglobins | 1 | 2003 | 28 | 0.010 |
Why?
| | Cell Line | 2 | 1998 | 2823 | 0.010 |
Why?
| | Mothers | 1 | 2009 | 765 | 0.010 |
Why?
| | Databases, Factual | 1 | 2008 | 1490 | 0.010 |
Why?
| | Training Support | 1 | 2002 | 35 | 0.010 |
Why?
| | Blood Pressure | 1 | 2009 | 1779 | 0.010 |
Why?
| | Receptors, Phospholipase A2 | 1 | 2001 | 1 | 0.010 |
Why?
| | Pharyngeal Neoplasms | 1 | 2001 | 4 | 0.010 |
Why?
| | Polymerase Chain Reaction | 2 | 1997 | 1041 | 0.010 |
Why?
| | Interleukin-3 | 1 | 2001 | 23 | 0.010 |
Why?
| | Annexin A5 | 1 | 2001 | 23 | 0.010 |
Why?
| | Vital Capacity | 1 | 2003 | 292 | 0.010 |
Why?
| | Food Contamination | 1 | 2001 | 33 | 0.010 |
Why?
| | Oxidants, Photochemical | 1 | 2001 | 8 | 0.010 |
Why?
| | Pancreatic Neoplasms | 1 | 2009 | 928 | 0.010 |
Why?
| | Disease Transmission, Infectious | 1 | 2001 | 69 | 0.010 |
Why?
| | Lysophospholipids | 1 | 2001 | 80 | 0.010 |
Why?
| | Mouth Neoplasms | 1 | 2001 | 90 | 0.010 |
Why?
| | Isoenzymes | 1 | 2001 | 294 | 0.010 |
Why?
| | Mutation | 1 | 1992 | 4075 | 0.010 |
Why?
| | Parents | 1 | 1989 | 1403 | 0.010 |
Why?
| | Fungi | 1 | 2001 | 121 | 0.010 |
Why?
| | Immunoenzyme Techniques | 1 | 2000 | 200 | 0.010 |
Why?
| | Melanoma | 2 | 1986 | 759 | 0.010 |
Why?
| | Extracellular Matrix | 1 | 2003 | 562 | 0.010 |
Why?
| | Reference Values | 1 | 2000 | 798 | 0.010 |
Why?
| | Ceruloplasmin | 1 | 1998 | 10 | 0.010 |
Why?
| | Boston | 1 | 1978 | 93 | 0.010 |
Why?
| | Fuel Oils | 1 | 1998 | 2 | 0.010 |
Why?
| | Enzyme Activation | 1 | 2000 | 762 | 0.010 |
Why?
| | Protein Biosynthesis | 1 | 2001 | 452 | 0.010 |
Why?
| | Histocytochemistry | 1 | 1998 | 78 | 0.010 |
Why?
| | Utah | 1 | 1998 | 79 | 0.010 |
Why?
| | Receptors, Transferrin | 1 | 1998 | 28 | 0.010 |
Why?
| | Cell Survival | 1 | 2001 | 1100 | 0.010 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 1998 | 132 | 0.010 |
Why?
| | Software | 1 | 2003 | 680 | 0.010 |
Why?
| | Thiourea | 1 | 1997 | 41 | 0.010 |
Why?
| | Autoradiography | 1 | 1997 | 66 | 0.010 |
Why?
| | Blotting, Western | 1 | 2000 | 1179 | 0.010 |
Why?
| | Respiratory Mucosa | 1 | 2000 | 322 | 0.010 |
Why?
| | Intubation, Intratracheal | 1 | 2000 | 325 | 0.010 |
Why?
| | Interferons | 1 | 1998 | 186 | 0.010 |
Why?
| | Sputum | 1 | 1978 | 302 | 0.010 |
Why?
| | Microsatellite Repeats | 1 | 1997 | 157 | 0.010 |
Why?
| | Heterozygote | 1 | 1997 | 313 | 0.010 |
Why?
| | Comorbidity | 1 | 2001 | 1661 | 0.010 |
Why?
| | Epithelium | 1 | 1997 | 310 | 0.010 |
Why?
| | Interleukin-8 | 1 | 1997 | 269 | 0.010 |
Why?
| | Age of Onset | 1 | 1998 | 555 | 0.010 |
Why?
| | Heart Defects, Congenital | 1 | 2004 | 910 | 0.010 |
Why?
| | Transfection | 1 | 1998 | 926 | 0.010 |
Why?
| | Protein Binding | 1 | 2001 | 2238 | 0.010 |
Why?
| | Skin Neoplasms | 1 | 1982 | 849 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2001 | 1454 | 0.010 |
Why?
| | Polymorphism, Genetic | 1 | 1997 | 614 | 0.010 |
Why?
| | Pacific Islands | 1 | 1994 | 5 | 0.010 |
Why?
| | West Virginia | 1 | 1993 | 9 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 1998 | 1246 | 0.010 |
Why?
| | Apoptosis | 1 | 2001 | 2440 | 0.010 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 1997 | 1217 | 0.010 |
Why?
| | Platelet Activating Factor | 1 | 1992 | 45 | 0.010 |
Why?
| | Prostaglandins | 1 | 1992 | 94 | 0.010 |
Why?
| | Primary Prevention | 1 | 1994 | 219 | 0.010 |
Why?
| | Respiratory Function Tests | 1 | 1994 | 544 | 0.010 |
Why?
| | Codon | 1 | 1992 | 92 | 0.010 |
Why?
| | DNA | 1 | 1998 | 1435 | 0.010 |
Why?
| | DNA, Neoplasm | 1 | 1992 | 158 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 1992 | 1048 | 0.010 |
Why?
| | Base Sequence | 1 | 1992 | 2170 | 0.000 |
Why?
| | Cognition | 1 | 1996 | 1266 | 0.000 |
Why?
| | Carcinoma, Bronchogenic | 1 | 1986 | 20 | 0.000 |
Why?
| | Eye Neoplasms | 1 | 1986 | 30 | 0.000 |
Why?
| | Carcinoma, Small Cell | 1 | 1987 | 172 | 0.000 |
Why?
| | Retinoblastoma | 1 | 1986 | 42 | 0.000 |
Why?
| | Feasibility Studies | 1 | 1990 | 1111 | 0.000 |
Why?
| | Lymphoma | 1 | 1986 | 237 | 0.000 |
Why?
| | Leukemia | 1 | 1986 | 246 | 0.000 |
Why?
| | Self Disclosure | 1 | 1984 | 61 | 0.000 |
Why?
| | Neck | 1 | 1982 | 108 | 0.000 |
Why?
| | Head | 1 | 1982 | 121 | 0.000 |
Why?
|
|
Samet's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|